Equities

Japan Animal Referral Medical Center Co Ltd

6039:TYO

Japan Animal Referral Medical Center Co Ltd

Actions
Consumer DiscretionaryConsumer Services
  • Price (JPY)2,230.00
  • Today's Change-9.00 / -0.40%
  • Shares traded1.50k
  • 1 Year change+28.09%
  • Beta0.9719
Data delayed at least 20 minutes, as of Nov 26 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in JPY

The one analyst offering a 12 month price target expects Japan Animal Referral Medicl Cntr Co Ltd share price to rise to 2,350.00 in the next year from the last price of 2,230.00.
High5.4%2,350.00
Med5.4%2,350.00
Low5.4%2,350.00

Dividends in JPY

In 2024, Japan Animal Referral Medical Center Co Ltd reported a dividend of 20.00 JPY. The analyst covering the company expects dividends of 25.00 JPY for the upcoming fiscal year, an increase of 25.00%.
Div growth (TTM)--
More ▼

Earnings history & estimates in JPY

Japan Animal Referral Medicl Cntr Co Ltd reported annual 2024 earnings of 123.01 per share on May 09, 2024.
Average growth rate+0.47%
More ▼

Revenue history & estimates in JPY

Japan Animal Referral Medical Center Co., Ltd. had 2nd quarter 2025 revenues of 1.32m. This bettered the 1.30m estimate of the one analyst covering the company. This was 38.45% above the prior year's 2nd quarter results.
Average growth rate+6.40%
Japan Animal Referral Medical Center Co., Ltd. had revenues for the full year 2024 of 4.27m. This was 10.25% above the prior year's results.
Average growth rate+12.26%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.